F-group (family)
633.15.1.1 BCDHK_Adom3
Ligands and drugs
175
Member domains
81
with ligand contacts (≤ 4 Å)
46.3% of members
77
with DrugDomain annotations
44.0% of members
54
with a DrugBank compound
30.9% of members
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
Chemical profiles are computed for X-groups. 633.15.1.1 belongs to X-group 633 Bromodomain-like, which binds 10.0 ligand superclasses per 20 proteins, broader than 94% of the 256 X-groups with enough proteins to compare. View its chemical profile →
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB08610 | TF3 | N-(2-AMINOETHYL)-2-{3-CHLORO-4-[(4-ISOPROPYLBENZYL)OXY]PHENYL} ACETAMIDE | 12 |
| DB03760 | RED | Dihydrolipoic Acid | 7 |
| DB06819 | CLT | Phenylbutyric acid | 2 |
| DB08608 | TF1 | 4-({(2R,5S)-2,5-DIMETHYL-4-[(2R)-3,3,3-TRIFLUORO-2-HYDROXY-2-METHYLPROPANOYL]PIPERAZIN-1-YL}CARBONYL)BENZONITRILE | 2 |
| DB08809 | TF4 | Dichloroacetic acid | 2 |
| DB00177 | U35 | Valsartan | 1 |
| DB00755 | — | Tretinoin | 1 |
| DB02930 | — | Adenosine 5'-[gamma-thio]triphosphate | 1 |
| DB03229 | COI | alpha-Ketoisocaproic acid | 1 |
| DB07403 | AZX | 4-[(3-CHLORO-4-{[(2R)-3,3,3-TRIFLUORO-2-HYDROXY-2-METHYLPROPANOYL]AMINO}PHENYL)SULFONYL]-N,N-DIMETHYLBENZAMIDE | 1 |
| DB08609 | TF2 | (2R)-N-{4-[Ethyl(phenyl)sulfamoyl]-2-methylphenyl}-3,3,3-trifluoro-2-hydroxy-2-methylpropanamide | 1 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| CL | CHLORIDE ION | 13 |
| Kmetal | POTASSIUM ION | 13 |
| TF3 | N-(2-AMINOETHYL)-2-{3-CHLORO-4-[(4-ISOPROPYLBENZYL)OXY]PHENYL} ACETAMIDE | 12 |
| RED | DIHYDROLIPOIC ACID | 6 |
| 0F1 | 3,6-dichloro-1-benzothiophene-2-carboxylic acid | 3 |
| 03H | (2S)-2-chloro-4-methylpentanoic acid | 2 |
| CLT | 4-PHENYL-BUTANOIC ACID | 2 |
| EGX | 1-(1-piperidin-4-ylpyrazol-4-yl)anthracene-9,10-dione | 2 |
| TF1 | 4-({(2R,5S)-2,5-DIMETHYL-4-[(2R)-3,3,3-TRIFLUORO-2-HYDROXY-2-METHYLPROPANOYL]PIPERAZIN-1-YL}CARBONYL)BENZONITRILE | 2 |
| TF4 | DICHLORO-ACETIC ACID | 2 |
| WJ1 | (S)-2-chloro-3-phenylpropanoic acid | 2 |
| XGG | (2P)-2-[(4P)-4-{6-[(1-ethylcyclopropyl)methoxy]pyridin-3-yl}-1,3-thiazol-2-yl]benzoic acid | 2 |
| XGT | (2M)-2-[2-(4-methylphenyl)-1,3-thiazol-4-yl]benzoic acid | 2 |
| A1L16 | (5~{R})-5-propan-2-ylindeno[1,2-b]pyridin-5-ol | 1 |
| A1L17 | methyl (9~{R})-9-oxidanyl-9-(trifluoromethyl)fluorene-4-carboxylate | 1 |
| AZX | 4-[(3-CHLORO-4-{[(2R)-3,3,3-TRIFLUORO-2-HYDROXY-2-METHYLPROPANOYL]AMINO}PHENYL)SULFONYL]-N,N-DIMETHYLBENZAMIDE | 1 |
| COI | 2-OXO-4-METHYLPENTANOIC ACID | 1 |
| HRI | ALPHA-CHLOROISOCAPROIC ACID | 1 |
| JP6 | 2-[(4-chlorophenyl)methylamino]-5-propyl-6~{H}-[1,2,4]triazolo[1,5-a]pyrimidin-7-one | 1 |
| MGmetal | MAGNESIUM ION | 1 |